Mariner, LLC Bio Rad Laboratories, Inc. Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Mariner, LLC holds 2,941 shares of BIO stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,941

Previous 2,907 1.17%

Holding current value

$1.01 Million

Previous $793,000 23.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$263.97 - $344.64 $8,974 - $11,717	34 Added 1.17%	2,941 $983,000
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $21,460 - $27,158	80 Added 2.83%	2,907 $793,000
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $31,019 - $35,902	102 Added 3.74%	2,827 $977,000
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $147,884 - $200,406	-549 Reduced 16.77%	2,725 $879,000
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $52,887 - $63,817	151 Added 4.84%	3,274 $1.17 Million
Q2 2023 Aug 11, 2023	SELL	$359.49 - $486.4 $299,814 - $405,657	-834 Reduced 21.08%	3,123 $1.18 Million
Q1 2023 May 12, 2023	BUY	$418.69 - $503.0 $111,790 - $134,301	267 Added 7.24%	3,957 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $415,017 - $538,091	1,180 Added 47.01%	3,690 $1.55 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $1.04 Million - $1.41 Million	2,510 New	2,510 $1.05 Million
Q3 2019 Nov 13, 2019	SELL	$304.55 - $345.24 $259,781 - $294,489	-853 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $9,468 - $10,315	33 Added 4.02%	853 $267,000
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $183,926 - $260,276	820 New	820 $251,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.45B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account